A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

BACKGROUND: Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen levels in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Urol
Autors principals: Miyazawa, Yoshiyuki, Sekine, Yoshitaka, Syuto, Takahiro, Nomura, Masashi, Koike, Hidekazu, Matsui, Hiroshi, Shibata, Yasuhiro, Ito, Kazuto, Suzuki, Kazuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5575925/
https://ncbi.nlm.nih.gov/pubmed/28851333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0261-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars